$5.45 Billion is the total value of Eventide Asset Management's 149 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 30.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MTD | Buy | METTLER TOLEDO INTERNATIONAL | $201,742,886 | +7.7% | 131,840 | +1.7% | 3.70% | +0.2% |
PANW | Buy | PALO ALTO NETWORKS INC | $171,642,974 | +73.8% | 859,332 | +21.4% | 3.15% | +61.7% |
DOCS | Buy | DOXIMITY INCcl a | $169,818,302 | +28.8% | 5,244,543 | +33.5% | 3.12% | +19.9% |
TT | Buy | TRANE TECHNOLOGIES PLC | $145,099,323 | +11.9% | 788,669 | +2.3% | 2.66% | +4.1% |
ROP | Buy | ROPER TECHNOLOGIES INC | $135,151,250 | +12.5% | 306,681 | +10.3% | 2.48% | +4.7% |
IDXX | Buy | IDEXX LABS INC | $129,019,140 | +22.7% | 257,997 | +0.1% | 2.37% | +14.2% |
EXAS | Buy | EXACT SCIENCES CORP | $126,637,616 | +37.0% | 1,867,536 | +0.0% | 2.32% | +27.4% |
ARGX | Buy | ARGENX SEsponsored adr | $122,547,523 | -1.6% | 328,916 | +0.0% | 2.25% | -8.5% |
WCN | Buy | WASTE CONNECTIONS INC | $112,546,013 | +5.2% | 809,276 | +0.3% | 2.06% | -2.1% |
POOL | Buy | POOL CORP | $91,820,834 | +22.9% | 268,137 | +8.5% | 1.68% | +14.4% |
GLBE | Buy | GLOBAL E ONLINE LTD | $90,012,073 | +56.2% | 2,792,804 | +0.0% | 1.65% | +45.3% |
ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $83,936,105 | -12.2% | 782,840 | +0.0% | 1.54% | -18.3% |
FIVN | Buy | FIVE9 INC | $77,021,381 | +8.8% | 1,065,450 | +2.2% | 1.41% | +1.3% |
HUBS | Buy | HUBSPOT INC | $76,480,854 | +48.3% | 178,381 | +0.0% | 1.40% | +38.0% |
DHI | Buy | D R HORTON INC | $67,223,908 | +9.6% | 688,135 | +0.0% | 1.23% | +2.0% |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $63,096,987 | +3.4% | 2,630,137 | +0.0% | 1.16% | -3.7% |
LRCX | Buy | LAM RESEARCH CORP | $62,008,667 | +28.1% | 116,971 | +1.6% | 1.14% | +19.2% |
SGEN | Buy | SEAGEN INC | $56,657,990 | +81.8% | 279,834 | +15.4% | 1.04% | +69.1% |
ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $55,504,400 | +27.8% | 3,227,000 | +49.6% | 1.02% | +18.9% |
SPT | Buy | SPROUT SOCIAL INC | $53,286,194 | +8.8% | 875,266 | +0.9% | 0.98% | +1.2% |
SWAV | Buy | SHOCKWAVE MED INC | $52,445,756 | +542.5% | 241,875 | +509.3% | 0.96% | +497.5% |
SHLS | Buy | SHOALS TECHNOLOGIES GROUP INcl a | $49,570,278 | +32.1% | 2,175,089 | +43.0% | 0.91% | +22.8% |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $49,462,008 | +23.3% | 2,059,201 | +0.1% | 0.91% | +14.7% |
ASML | Buy | ASML HOLDING N V | $47,120,108 | +24.8% | 69,222 | +0.2% | 0.86% | +16.1% |
GH | Buy | GUARDANT HEALTH INC | $43,950,469 | -3.9% | 1,875,020 | +11.5% | 0.81% | -10.6% |
XMTR | Buy | XOMETRY INC | $43,456,847 | -35.9% | 2,902,929 | +38.0% | 0.80% | -40.4% |
TREX | Buy | TREX CO INC | $42,938,329 | +15.0% | 882,234 | +0.0% | 0.79% | +7.1% |
HASI | Buy | HANNON ARMSTRONG SUST INFR C | $40,610,942 | +70.3% | 1,419,963 | +72.6% | 0.74% | +58.5% |
CWEN | Buy | CLEARWAY ENERGY INCcl c | $40,626,363 | +10.1% | 1,296,724 | +12.0% | 0.74% | +2.3% |
COUR | Buy | COURSERA INC | $39,202,813 | -1.6% | 3,403,022 | +1.0% | 0.72% | -8.5% |
VRSK | Buy | VERISK ANALYTICS INC | $38,580,936 | +27.0% | 201,089 | +16.8% | 0.71% | +18.2% |
RPRX | Buy | ROYALTY PHARMA PLC | $37,799,541 | +27.8% | 1,049,113 | +40.2% | 0.69% | +19.0% |
ENPH | Buy | ENPHASE ENERGY INC | $35,974,913 | -20.2% | 171,081 | +0.6% | 0.66% | -25.8% |
KDNY | Buy | CHINOOK THERAPEUTICS INC | $33,325,907 | +244.9% | 1,439,564 | +290.3% | 0.61% | +219.9% |
CDW | Buy | CDW CORP | $33,091,348 | +19.4% | 169,795 | +9.4% | 0.61% | +11.2% |
APLS | Buy | APELLIS PHARMACEUTICALS INC | $32,650,200 | +86.1% | 495,000 | +45.9% | 0.60% | +73.1% |
NARI | Buy | INARI MED INC | $31,667,310 | +42.5% | 512,914 | +46.7% | 0.58% | +32.6% |
VECT | Buy | VECTIVBIO HLDG AG | $31,610,538 | +7.8% | 3,675,644 | +7.9% | 0.58% | +0.3% |
SNPS | Buy | SYNOPSYS INC | $30,788,760 | +49.8% | 79,712 | +23.8% | 0.56% | +39.5% |
LAD | New | LITHIA MTRS INC | $28,730,486 | – | 125,499 | +100.0% | 0.53% | – |
PLD | Buy | PROLOGIS INC. | $27,226,810 | +299.4% | 218,216 | +260.9% | 0.50% | +273.1% |
BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $27,100,335 | +27.0% | 775,403 | +0.0% | 0.50% | +18.1% |
SRPT | New | SAREPTA THERAPEUTICS INC | $25,811,148 | – | 187,268 | +100.0% | 0.47% | – |
ORLY | Buy | OREILLY AUTOMOTIVE INC | $25,829,368 | +16177.9% | 30,424 | +16083.0% | 0.47% | +15700.0% |
Buy | AURA BIOSCIENCES INC | $23,439,702 | -0.8% | 2,525,830 | +12.2% | 0.43% | -7.7% | |
AJG | Buy | GALLAGHER ARTHUR J & CO | $22,910,903 | +32.0% | 119,758 | +30.1% | 0.42% | +22.8% |
TRGP | Buy | TARGA RES CORP | $22,829,630 | +122.6% | 312,949 | +124.2% | 0.42% | +107.4% |
Buy | MARINUS PHARMACEUTICALS INC | $21,895,059 | +74.6% | 3,173,197 | +0.7% | 0.40% | +62.8% | |
KLAC | Buy | KLA CORP | $20,421,138 | +7.1% | 51,159 | +1.2% | 0.38% | -0.3% |
NOVT | Buy | NOVANTA INC | $20,038,022 | +17.1% | 125,954 | +0.0% | 0.37% | +9.2% |
ISRG | Buy | INTUITIVE SURGICAL INC | $19,167,659 | -3.7% | 75,029 | +0.0% | 0.35% | -10.2% |
NTLA | Buy | INTELLIA THERAPEUTICS INC | $18,382,384 | +65.2% | 493,222 | +54.6% | 0.34% | +53.9% |
FGEN | New | FIBROGEN INC | $17,913,600 | – | 960,000 | +100.0% | 0.33% | – |
BRKR | Buy | BRUKER CORP | $17,408,109 | +26.1% | 220,803 | +9.3% | 0.32% | +17.3% |
ELS | Buy | EQUITY LIFESTYLE PPTYS INC | $16,563,455 | +107.8% | 246,737 | +100.0% | 0.30% | +93.6% |
BLU | New | BELLUS HEALTH INC NEW | $15,912,000 | – | 2,210,000 | +100.0% | 0.29% | – |
BBIO | New | BRIDGEBIO PHARMA INC | $15,604,698 | – | 941,176 | +100.0% | 0.29% | – |
INSM | Buy | INSMED INC | $15,551,356 | +11.4% | 912,103 | +30.6% | 0.28% | +3.6% |
RCKT | Buy | ROCKET PHARMACEUTICALS INC | $15,382,740 | +67.0% | 898,000 | +90.8% | 0.28% | +54.9% |
SYY | Buy | SYSCO CORP | $14,776,648 | +9.1% | 191,333 | +8.0% | 0.27% | +1.5% |
SHW | Buy | SHERWIN WILLIAMS CO | $14,550,261 | +14.7% | 64,734 | +21.1% | 0.27% | +6.8% |
AKRO | New | AKERO THERAPEUTICS INC | $14,505,131 | – | 379,120 | +100.0% | 0.27% | – |
BEAM | Buy | BEAM THERAPEUTICS INC | $14,060,796 | +34.6% | 459,203 | +72.0% | 0.26% | +25.2% |
AESC | New | AES CORPunit 02/15/2024 | $13,999,364 | – | 156,400 | +100.0% | 0.26% | – |
MRTX | Buy | MIRATI THERAPEUTICS INC | $13,797,572 | +49.6% | 371,102 | +82.3% | 0.25% | +39.0% |
Buy | AMYLYX PHARMACEUTICALS INC | $13,439,304 | +45.5% | 458,054 | +83.2% | 0.25% | +35.7% | |
ZIP | New | ZIPRECRUITER INCcl a | $13,030,552 | – | 817,475 | +100.0% | 0.24% | – |
KROS | New | KEROS THERAPEUTICS INC | $12,810,000 | – | 300,000 | +100.0% | 0.24% | – |
Buy | GXO LOGISTICS INCORPORATED | $11,104,985 | +18.2% | 220,075 | +0.0% | 0.20% | +10.3% | |
ETNB | New | 89BIO INC | $9,778,772 | – | 642,073 | +100.0% | 0.18% | – |
BCRX | New | BIOCRYST PHARMACEUTICALS INC | $9,198,094 | – | 1,102,889 | +100.0% | 0.17% | – |
New | R1 RCM INC | $8,933,535 | – | 595,569 | +100.0% | 0.16% | – | |
CERE | New | CEREVEL THERAPEUTICS HLDNG I | $7,609,680 | – | 312,000 | +100.0% | 0.14% | – |
DNLI | New | DENALI THERAPEUTICS INC | $7,220,897 | – | 313,407 | +100.0% | 0.13% | – |
CRNX | New | CRINETICS PHARMACEUTICALS IN | $6,982,374 | – | 434,768 | +100.0% | 0.13% | – |
New | NEXTERA ENERGY INCunit 09/01/2025 | $3,476,250 | – | 75,000 | +100.0% | 0.06% | – | |
PTCT | New | PTC THERAPEUTICS INC | $1,649,237 | – | 34,047 | +100.0% | 0.03% | – |
WDAY | Buy | WORKDAY INCcl a | $449,431 | +45.4% | 2,176 | +17.8% | 0.01% | +33.3% |
EW | Buy | EDWARDS LIFESCIENCES CORP | $333,402 | +71.4% | 4,030 | +54.6% | 0.01% | +50.0% |
NOW | Buy | SERVICENOW INC | $333,669 | +80.5% | 718 | +50.8% | 0.01% | +50.0% |
NEE | Buy | NEXTERA ENERGY INC | $277,026 | +50.1% | 3,594 | +62.8% | 0.01% | +25.0% |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $188,552 | +63.9% | 2,027 | +31.3% | 0.00% | +50.0% |
GNRC | New | GENERAC HLDGS INC | $11,125 | – | 103 | +100.0% | 0.00% | – |
DLO | New | DLOCAL LTDcall | $70 | – | 3,900 | +100.0% | 0.00% | – |
MDB | New | MONGODB INCcl a | $18,883 | – | 81 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 40 | Q3 2023 | 3.2% |
PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
VERACYTE INC | 38 | Q3 2023 | 1.5% |
LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.